Evidence map›Paper›PMID 27308616›Full record

ArticleMolecular & cellular oncology2016

ATG2B and GSKIP: 2 new genes predisposing to myeloid malignancies.

Isabelle Plo, Christine Bellanné-Chantelot, William Vainchenker

Abstract read
In one paragraph

Article in Molecular & cellular oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Isabelle PloINSERM, UMR 1170, Gustave Roussy, Villejuif, France; Université Paris-Sud, UMR1170, Gustave Roussy, Villejuif, France; Gustave Roussy, Villejuif France.
Christine Bellanné-ChantelotINSERM, UMR 1170, Gustave Roussy, Villejuif, France; Department of Genetics, AP-HP Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France; Université Pierre et Marie Curie, Paris, France UMR U1170, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France.
William VainchenkerINSERM, UMR 1170, Gustave Roussy, Villejuif, France; Université Paris-Sud, UMR1170, Gustave Roussy, Villejuif, France; Gustave Roussy, Villejuif France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have recently identified a 700-kb tandem duplication at locus 14q32.13-q32.2 involving 2 genes, autophagy-related protein 2 homolog B (ATG2B) and GSK3B interacting protein (GSKIP), that increases the predisposition to myeloid malignancies. Here, we discuss the clinical relevance of these findings.

Indexed as

ATG2Bchromosome 14GSKIPleukemiamyeloproliferative neoplasm

Identifiers

PMID27308616
PMCPMC4905402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.